Tag: Inspection
In a move that has both nutritionists and food scientists raising their kale smoothies in approval, the FDA announced on May 9, 2025, the approval of three new natural food color additives. This decision marks a significant step in the Department of Health and Human Services’ (HHS) initiative to modernize the color additive regulations and […]
FDA Announces Expanded Use of Unannounced Foreign Inspections
In what can only be described as the regulatory equivalent of “We were in the neighborhood…”, the U.S. Food and Drug Administration (FDA) announced May 6, 2025, its expanded use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines and other medical products intended for American consumers and patients. Yes, you read […]
A Closer Look at the Potential Inspection Shift, State Oversight and How to Stay Compliant
The Great Inspection Shake-Up: FDA’s New Recipe In the grand kitchen of U.S. food safety, the FDA has long played head chef—stirring up regulations, inspecting operations, and occasionally flipping a facility on its lid when things got unsanitary. But in 2025, the kitchen dynamics are shifting, with many wondering if the Agency is stepping away […]
A Tighter Grip on Talc and Asbestos Testing
New Year, new regulations—(kind of)! As we step into 2025, the U.S. Food and Drug Administration (FDA) has decided that it’s time to give the talc industry a little more TLC—specifically when it comes to testing for the sneaky mineral asbestos. It’s a big deal because, as we all know, asbestos and talc are akin […]
FDA’s Photo Policy Snaps Back
When the U.S. Food and Drug Administration (FDA) comes knocking for an inspection, a company’s usual concerns revolve around compliance, spotless records, and a robust quality system. However, one detail that has increasingly drawn attention has been the FDA’s practice of taking photographs during inspections. This seemingly minor aspect recently became a flashpoint, as highlighted […]
Navigating FDA’s Complex Regulation of Homeopathic and Ayurvedic Products
In an era where natural and alternative medicines continue to gain traction driven by a growing interest in holistic and natural health alternatives, the U.S. Food and Drug Administration (FDA) finds itself at the intersection of tradition and science. Homeopathic and ayurvedic products, rooted in centuries-old practices, have become a sizeable industry in the United […]
Countdown to Cosmetics Compliance and the Upcoming Deadline
As the July 1 st deadline for compliance with the Modernization of Cosmetics Regulation Act (MoCRA) rapidly approaches, cosmetic companies are glamorously gearing up to meet the new regulatory requirements set forth by this landmark legislation. As a reminder, MoCRA represents a significant overhaul of the regulatory framework governing the cosmetics industry, ushering in a […]
FDA Makes Changes to Device GMPs to Align More Closely with International Consensus Standards.
On January 31, 2024, FDA issued a final rule, which will amend medical device current good manufacturing practice (cGMP) requirements of the Quality System (QS) Regulation under 21 CFR Part 820, to more closely align with the international consensus standard for Quality Management Systems for medical devices used by many other regulatory authorities around the […]
Grace and Courtesy During an FDA Inspection: FDA’s New Guidance on What Constitutes Refusal of Inspection by a Foreign Food Establishment or Foreign Government
★★★★★
Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
